Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Human Growth Hormone Market Be Worth By 2029?

There has been a notable expansion in the human growth hormone market recently. A predicted escalation from $4.75 billion in 2024 to $5.18 billion in 2025 is foreseen, showing a compound annual growth rate (CAGR) of 9.0%. The previous growth can be traced back to a rising frequency of growth disorders, increased consciousness about hormone treatments, widening uses in sports medicine, an aging population, and an enhancement in the healthcare infrastructure.

The market size for human growth hormone is predicted to experience robust growth in the forthcoming years. It is expected to reach $7.32 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.0%. This anticipated growth over the predicted period can be credited to the rise of personalized medicine, elevated healthcare spending worldwide, the growing use of recombinant DNA technology, increased demand for hormone replacement therapies and a higher incidence of endocrine disorders. Key trends for the forecast period include the enlargement of distribution networks in developing markets, the incorporation of artificial intelligence into drug development, focus on eco-friendly manufacturing procedures, the creation of long-acting formulations, and the use of combination therapies for increased effectiveness.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15825&type=smp

What Market Forces Are Contributing To The Growth Of The Human Growth Hormone Market?

The anticipated growth of the human growth hormone market is linked to increased awareness about treatment procedures. Treatment plans are strategically implemented to mitigate, control, or eliminate medical conditions. The surge in the understanding and knowledge of these procedures stems from innovations in the medical field, an increased availability of information through digital channels, and an amplified public emphasis on health and well-being. Procedures related to human growth hormone (HGH) treatments have significantly piqued public interest due to their media coverage, underlining the advantages and possibilities of modern medical treatments, which in turn raises broader awareness of such intervention methods. For example, the 2022 National Survey on Drug Use and Health (NSDUH), published in November 2023 by the Substance Abuse and Mental Health Services Administration (SAMHSA)—a Department of Health and Human Services in the US—indicated that 40.6% of the 5.0 million adolescents aged 12 to 17 had a Major Depressive Episode (MDE) in 2021 and received treatment. The same report showed that in 2022, 56.8% of the 4.8 million adolescents with an MDE in the past year got mental health therapy. Consequently, the growing awareness of treatment procedures is directing the progress of the human growth hormone market.

Which Segments Define The Structure Of The Human Growth Hormone Market?

The human growth hormonemarket covered in this report is segmented –

1) By Product: Liquid; Powder

2) By Brand: Norditropin; Genotropin; Humatrope; Saizen; Omnitrope; Skytrofa; Others Brands

3) By Route Of Administration: Oral; Intravenous; Intramuscular; Subcutaneous

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacy; Specialty Pharmacy

5) By Application: Growth Hormone (GH) Deficiency; Adult Growth Hormone (GH) Deficiency; Pediatric Growth Hormone (GH) Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader-Willi Syndrome; Small For Gestational Age; Other Applications

Subsegments:

1) By Liquid: Pre-Filled Liquid Syringes; Vials Of Liquid Growth Hormone

2) By Powder: Reconstitutable Powder; Freeze-Dried Powder

What Strategic Shifts And Innovations Are Influencing The Human Growth Hormone Market?

Leading companies in the human growth hormone market are concentrating more on drug development and gaining necessary approvals to enhance their medicinal offerings and provide superior treatment solutions. The process of drug development is intricate and stringent, involving several phases to verify a new drug’s safety, effectiveness, and quality before it is introduced in the market. For example, in June 2023, Pfizer Inc., a biopharmaceutical company based in the US, and OPKO Health Inc., an American biopharmaceutical and diagnostics firm, reported the approval of NGENLA (somatrogon-ghla) by the Food and Drug Administration (FDA). This treatment option provides a simpler dosing schedule and enhances patient compliance compared to everyday injections. Children suffering from growth hormone deficiency now have the opportunity to reduce their injection frequency from daily to once weekly. The FDA endorsed this approval backed by a Phase 3 study, demonstrating NGENLA’s non-inferiority when compared to once-daily somatropin, with a safety profile akin to somatropin.

Which Firms Are Making The Biggest Impact In The Human Growth Hormone Market?

Major companies operating in the human growth hormone market are Pfizer Inc., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen Pharma, Ferring Holding SA, Endo International, Zydus Lifesciences Limited, Opko Health, LG Life Sciences, EMD Serono Inc., Wockhardt Ltd., JCR Pharmaceuticals Co. Ltd., Genentech Inc., Shanghai United Imaging Healthcare Co. Ltd., SOFAR S.p.A., United Laboratories, Ascendis Pharma, Uni-Pharma S.A., Versartis Inc., Reliance Life Sciences, Anhui Anke Biotechnology (Group) Co. Ltd., Rani Therapeutics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report

Which Region Is Forecasted To Lead The Human Growth Hormone Market In The Coming Years?

North America was the largest region in the human growth hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human growth hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15825&type=smp

Browse Through More Reports Similar to the Global Human Growth Hormone Market 2025, By The Business Research Company

Biosimilar Growth Hormone Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

Parathyroid Hormones Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Biosimilar Hormone Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model